Opinion|Videos|November 21, 2024
Anticipating Advances for Pediatric Vitiligo
Author(s)Lisa Swanson, MD, FAAD
Key Takeaways
- Targeted biologics and JAK inhibitors show promise in modulating immune responses and promoting repigmentation in pediatric vitiligo.
- Advancements in phototherapy and laser treatments offer improved efficacy and safety profiles for children with vitiligo.
The panelist discusses advances in targeted therapies, including novel biologics and small molecules, as well as the development of personalized treatment approaches tailored to individual patient characteristics, which hold great promise for improving outcomes and enhancing the quality of life for children living with vitiligo in the future.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What advances in research or new therapies do you believe hold the most promise for improving outcomes in pediatric vitiligo treatment?
- How do you envision the future of vitiligo management for children, particularly in the context of personalized medicine and innovative treatment strategies?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Reviewing Type 2 Inflammation Through a Different Lens
4
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
5
